Adaptive Biotechnologies Corp (ADPT) Insider Trading
- $5,244,000.00
- $564,891,829.35
- Nov. 18, 2024
- Chad M Robins
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Nov. 18, 2024 | CFO | 248 | $4.98 | Sell | $1,235.04 | |
March 5, 2024 | President | 39,070 | $3.47 | Sell | $135,572.90 | |
March 5, 2024 | Insider | 7,727 | $3.43 | Sell | $26,503.61 | |
March 5, 2024 | SVP | 13,381 | $3.43 | Sell | $45,896.83 | |
March 5, 2024 | CEO | 48,673 | $3.43 | Sell | $166,948.39 | |
March 5, 2024 | CFO | 15,456 | $3.44 | Sell | $53,168.64 | |
Nov. 16, 2023 | Insider | 259 | $4.13 | Sell | $1,069.67 | |
Aug. 7, 2023 | Insider | 5,652 | $6.78 | Sell | $38,320.56 | |
June 20, 2023 | CFO | 134,961 | $8.14 | Sell | $1,098,582.54 | |
June 15, 2023 | CFO | 70,000 | $8.53 | Sell | $597,100.00 | |
June 2, 2023 | CFO | 38,000 | $7.16 | Sell | $272,080.00 | |
April 10, 2023 | COO | 817 | $8.50 | Sell | $6,944.50 | |
March 27, 2023 | Director | 2,341 | $8.49 | Sell | $19,875.09 | |
March 6, 2023 | Insider | 3,529 | $8.57 | Sell | $30,243.53 | |
March 6, 2023 | SVP | 5,491 | $8.57 | Sell | $47,057.87 | |
March 6, 2023 | COO | 6,529 | $8.57 | Sell | $55,953.53 | |
March 6, 2023 | President | 22,668 | $8.57 | Sell | $194,264.76 | |
Jan. 9, 2023 | COO | 995 | $8.50 | Sell | $8,457.50 | |
Nov. 16, 2022 | Insider | 959 | $8.87 | Sell | $8,506.33 | |
Nov. 1, 2022 | Insider | 31,066 | $8.00 | Sell | $248,528.00 | |
Oct. 10, 2022 | COO | 2,284 | $7.13 | Sell | $16,284.92 | |
Oct. 7, 2022 | COO | 841 | $7.61 | Sell | $6,400.01 | |
Aug. 5, 2022 | Insider | 17,540 | $10.98 | Sell | $192,589.20 | |
July 8, 2022 | Chief Operating Officer | 2,300 | $10.47 | Sell | $24,081.00 | |
July 7, 2022 | COO | 825 | $9.53 | Sell | $7,862.25 | |
July 7, 2022 | Chief Operating Officer | 825 | $9.53 | Sell | $7,862.25 | |
April 7, 2022 | COO | 831 | $13.17 | Sell | $10,944.27 | |
March 9, 2022 | CEO | 14,815 | $12.46 | Sell | $184,594.90 | |
March 7, 2022 | SVP | 1,569 | $12.01 | Sell | $18,843.69 | |
March 7, 2022 | COO | 1,244 | $12.01 | Sell | $14,940.44 | |
March 7, 2022 | Insider | 2,373 | $12.01 | Sell | $28,499.73 | |
March 7, 2022 | President | 4,613 | $12.01 | Sell | $55,402.13 | |
March 7, 2022 | CEO | 4,424 | $12.01 | Sell | $53,132.24 | |
Dec. 22, 2021 | SVP | 15,338 | $30.00 | Sell | $460,140.00 | |
Dec. 22, 2021 | CFO | 10,000 | $30.00 | Sell | $300,000.00 | |
Nov. 18, 2021 | Insider | 300 | $31.36 | Sell | $9,408.00 | |
Nov. 9, 2021 | CFO | 5,000 | $36.03 | Sell | $180,150.00 | |
Oct. 21, 2021 | Insider | 3,700 | $33.73 | Sell | $124,801.00 | |
Oct. 19, 2021 | Insider | 3,800 | $33.69 | Sell | $128,022.00 | |
Oct. 8, 2021 | Insider | 3,895 | $32.96 | Sell | $128,379.20 | |
Oct. 7, 2021 | COO | 1,324 | $32.47 | Sell | $42,990.28 | |
Oct. 6, 2021 | Insider | 3,895 | $32.27 | Sell | $125,691.65 | |
Oct. 6, 2021 | CFO | 5,000 | $32.30 | Sell | $161,500.00 | |
Sept. 14, 2021 | Insider | 3,895 | $36.74 | Sell | $143,102.30 | |
Sept. 10, 2021 | CEO | 5,000 | $38.38 | Sell | $191,900.00 | |
Sept. 8, 2021 | CEO | 13,746 | $38.45 | Sell | $528,533.70 | |
Sept. 7, 2021 | SVP | 495 | $40.00 | Sell | $19,800.00 | |
Sept. 7, 2021 | CFO | 9,375 | $39.71 | Sell | $372,281.25 | |
Aug. 27, 2021 | Director | 14,916 | $35.00 | Sell | $522,060.00 | |
Aug. 27, 2021 | Insider | 3,895 | $34.78 | Sell | $135,468.10 |
Insiders are both buying and selling Adaptive Biotechnologies Corp stock.
The insider traders at Adaptive Biotechnologies Corp are: Chad M Robins, Harlan S Robins, Julie Rubinstein, Chad M Cohen, Stacy L Taylor, Sharon Benzeno, R Mark Adams, Lance Baldo, Michelle Renee Griffin, Francis Lo, Nancy Louise Hill, Eric Dobmeier, Robert Hershberg, Kyle Piskel, Jyoti Palaniappan, Tycho Peterson, Charles Sang, David E Goel, Nitin Sood, Viking Global Performance Llc, Chad M. Robins, Global Investors Lp Viking, Harlan S. Robins, ADAMS R MARK, Chad M. Cohen, Susan Bobulsky, Andris A Zoltners, and Michael J Pellini
The most active insider trader at Adaptive Biotechnologies Corp is Chad M Robins with 37 trades.
Viking Global Performance Llc has sold the most Adaptive Biotechnologies Corp stock with a total value of $245,448,434.04.
Viking Global Performance Llc has bought the most Adaptive Biotechnologies Corp stock with a total value of $10,000,000.00.
The most recent insider trade for Adaptive Biotechnologies Corp was on Nov. 18, 2024.
The single biggest insider buy for Adaptive Biotechnologies Corp was from Viking Global Performance Llc with a total value of $5,000,000.00 on July 1, 2019.
The single biggest insider sell for Adaptive Biotechnologies Corp was from Global Investors Lp Viking with a total value of $123,800,000.00 on Nov. 11, 2020.